
    
      Upon determination of eligibility, patients will receive:

      Pre-operative

        -  Docetaxel

        -  Gemcitabine Post-operative

        -  Docetaxel

        -  Carboplatin

        -  Radiation Therapy

      Patients with stage IB and II NSCLC who achieved clear margins will not receive any further
      therapy. Patients with incomplete resection, resection margins of a T3 tumor that are
      positive or close, stage IIIA AND IIIB NSCLC or disease judged unresectable after
      preoperative chemotherapy will receive postoperative treatment
    
  